Pacific Biosciences of Californ Price Today
Pacific Biosciences of Californ
PACB
Healthcare
$924.43M
💰
Market Cap
0
💸
Price to Earnings
$-1.2
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
10 |
Strong Buy |
4 |
Hold |
6 |
Sell |
0 |
Strong Sell |
0 |
PACB Price Forecast Target
3.5 👉 20.0 +480%
PACB EPS Forecast
-1.2 👉 -0.9 +-29%
Financials
Profit Margin
-153 %
Revenue Growth
113.3 %
Dividend
$ 0
Held Percent
2.8% - Insiders
101.8% - Institutions
-4.6% - Public
Major Fund Holders
-
💰 ARK Investment Management, LLC $119.0M
-
💰 Vanguard Group Inc $92.4M
-
💰 Blackrock Inc. $85.0M
-
💰 Madrone Advisors, LLC $60.7M
-
💰 Sumitomo Mitsui Trust Holdings, Inc. $45.5M
Stock Ideas
Stanley Druckenmiller Portfolio
Stanley Druckenmiller is a legendary hedge fund manager who has made billions of dollars for his investors. His current portfolio is heavily invested in gold, silver, and other precious metals. He also owns shares in several technology and healthcar…
Larry Robbins Portfolio
Larry Robbins is a successful hedge fund manager who founded Glenview Capital in 2001 after working as a trader at Omega Advisors. His portfolio strategy has led to impressive returns, with Glenview Capital returning 301% after fees and expenses bet…
Paul Tudor Jones Portfolio
Paul Tudor Jones is a pioneer in macro trading and founder of Tudor Investment Corporation, one of the earliest pioneering hedge funds. With over 40 years of experience investing across global markets, Jones strategically allocates capital based on …
Bill Gates Portfolio
With a portfolio valued at over $18 billion, the Bill & Melinda Gates Foundation Trust holds the endowment and funds the Bill & Melinda Gates Foundation. Bill and Melinda are the trustees for the Foundation Trust, and the endowment is managed by a t…📮FAQ
Some Frequently Asked Questions.
The Pacific Biosciences of Californ industry is Medical Devices
The Pacific Biosciences of Californ sector is Healthcare
The Pacific Biosciences of Californ forecasted predicted Price to Earnings PE ratio is -4.0
The Pacific Biosciences of Californ Price to Earnings PE ratio is 0
The Market Capitalization of Pacific Biosciences of Californ is $924.43M
There are total of 266435272 float shares with 101.8% held by Institutions and 2.8% held by insiders
The MPacific Biosciences of Californ forecasted Earnings per Share EPS is $-0.9
The Pacific Biosciences of Californ Earnings per Share EPS is -1.2
The Pacific Biosciences of Californ company has $0 gross profits with -153 profit margins
The Pacific Biosciences of Californ Earnings Growth is 0% with 0% quarterly earnings growth
The Pacific Biosciences of Californ Revenue is $200520992 with 1.133 revenue growth
The price target for Pacific Biosciences of Californ stock is $20.0 for the high target and $6.5 for the low target
The consensus analyst recommendations for Pacific Biosciences of Californ is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Pacific Biosciences of Californ is Buy, with the following breakdown:
- Buy: 10
- Strong Buy: 4
- Hold: 6
- Sell: 0
- Strong Sell: 0
The Beta of Pacific Biosciences of Californ is 1.9
The dividend of Pacific Biosciences of Californ is $0
The dividend yield of Pacific Biosciences of Californ is 0%
The biggest institutional and mutual fund holders of Pacific Biosciences of Californ stock are
- ARK Investment Management, LLC
- Vanguard Group Inc
- Blackrock Inc.
- Madrone Advisors, LLC
The Pacific Biosciences of Californ ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0